Home › Compare › CORBF vs GBDC

CORBF vs GBDC: Dividend Comparison 2026

CORBF yields 190.48% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CORBF wins by $69.40M in total portfolio value
10 years
CORBF
CORBF
● Live price
190.48%
Share price
$1.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.25M
Annual income
$44,400,251.00
Full CORBF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — CORBF vs GBDC

📍 CORBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCORBFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CORBF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CORBF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CORBF
Annual income on $10K today (after 15% tax)
$16,190.48/yr
After 10yr DRIP, annual income (after tax)
$37,740,213.35/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, CORBF beats the other by $23,757,089.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CORBF + GBDC for your $10,000?

CORBF: 50%GBDC: 50%
100% GBDC50/50100% CORBF
Portfolio after 10yr
$55.55M
Annual income
$30,425,492.42/yr
Blended yield
54.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CORBF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
4.7
Piotroski
8/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CORBF buys
0
GBDC buys
0
No recent congressional trades found for CORBF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCORBFGBDC
Forward yield190.48% ✓11.86%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$90.25M ✓$20.85M
Annual income after 10y$44,400,251.00 ✓$16,450,733.83
Total dividends collected$84.82M ✓$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: CORBF vs GBDC ($10,000, DRIP)

YearCORBF PortfolioCORBF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$29,748$19,047.62$12,492$1,791.70+$17.3K → CORBF
2$84,785$52,955.26$16,527$3,160.58+$68.3K → CORBF
3$231,777$141,056.55$23,588$5,904.90+$208.2K → CORBF
4$608,380$360,378.77$37,141$11,901.65+$571.2K → CORBF
5$1,535,024$884,057.33$66,205$26,463.38+$1.47M → CORBF
6$3,727,144$2,084,668.10$137,452$66,612.65+$3.59M → CORBF
7$8,718,621$4,730,577.40$342,372$195,298.53+$8.38M → CORBF
8$19,670,865$10,341,940.93$1,053,292$686,954.33+$18.62M → CORBF
9$42,854,727$21,806,900.51$4,111,439$2,984,416.95+$38.74M → CORBF
10$90,254,808$44,400,251.00$20,849,974$16,450,733.83+$69.40M → CORBF

CORBF vs GBDC: Complete Analysis 2026

CORBF — Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Full CORBF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CORBF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CORBF vs SCHDCORBF vs JEPICORBF vs OCORBF vs KOCORBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.